Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 27 entries
View as:

Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06180096 Org: User:
Start: 03/07/23 End: 04/06/23 Due: 04/06/24

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05082662 Org: User:
Start: 08/25/20 End: 09/16/20 Due: 09/16/21

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05082753 Org: User:
Start: 11/19/20 End: 12/21/20 Due: 12/21/21

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT04817800 Org: User:
Start: 03/25/21 End: 04/10/21 Due: 04/10/22

Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)

Phase: N/A Priority: Normal
NCT ID: NCT06932198 Org: User:
Start: 01/09/25 End: 03/25/25 Due: 03/25/26

Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

Phase: N/A Priority: Normal
NCT ID: NCT06553924 Org: User:
Start: 05/14/24 End: 08/08/24 Due: 08/08/25

Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06084663 Org: User:
Start: 02/15/23 End: 04/25/23 Due: 04/25/24

Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06484673 Org: User:
Start: 04/21/24 End: 05/27/24 Due: 05/27/25

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT06180083 Org: User:
Start: 03/24/23 End: 07/05/23 Due: 07/05/24

Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06592300 Org: User:
Start: 07/06/24 End: 09/13/24 Due: 09/13/25

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT06923956 Org: User:
Start: 12/04/24 End: 02/08/25 Due: 02/08/26

Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Phase: N/A Priority: Normal
NCT ID: NCT06180109 Org: User:
Start: 07/30/23 End: 10/06/23 Due: 10/06/24

To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT07039890 Org: User:
Start: 03/08/25 End: 06/05/25 Due: 06/05/26

To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06930937 Org: User:
Start: 08/30/24 End: 11/11/24 Due: 11/11/25

Bioequivalence Study of Perampanel Tablets 12 mg

Phase: N/A Priority: Normal
NCT ID: NCT06450223 Org: User:
Start: 09/14/23 End: 12/05/23 Due: 12/05/24

Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06450275 Org: User:
Start: 01/03/24 End: 03/07/24 Due: 03/07/25

Bioequivalence Study of Perampanel Tablets 10 mg

Phase: N/A Priority: Normal
NCT ID: NCT06450236 Org: User:
Start: 11/22/23 End: 02/06/24 Due: 02/06/25

Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)

Phase: N/A Priority: Normal
NCT ID: NCT06180057 Org: User:
Start: 06/12/22 End: 08/15/22 Due: 08/15/23

Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg

Phase: N/A Priority: Normal
NCT ID: NCT06553937 Org: User:
Start: 05/10/24 End: 07/31/24 Due: 07/31/25

Bioequivalence Study of Pimavanserin 34 mg Capsule

Phase: N/A Priority: Normal
NCT ID: NCT06450184 Org: User:
Start: 01/11/24 End: 03/09/24 Due: 03/09/25

Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06932159 Org: User:
Start: 12/23/24 End: 04/08/25 Due: 04/08/26

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06043297 Org: User:
Start: 02/23/23 End: 04/27/23 Due: 04/27/24

Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT04639869 Org: User:
Start: 06/26/19 End: 08/27/19 Due: 08/27/20

Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)

Phase: N/A Priority: Normal
NCT ID: NCT06180070 Org: User:
Start: 08/29/23 End: 10/16/23 Due: 10/16/24

Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

Phase: N/A Priority: Normal
NCT ID: NCT06557603 Org: User:
Start: 03/06/24 End: 07/22/24 Due: 07/22/25